NCT03245515View on ClinicalTrials.gov

A Study of BMS-986195 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

September 22, 2017

Study Completion Date

October 5, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BMS-986195

specified dose on specified days

Trial Locations (1)

9728 NZ

Local Institution, Groningen

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY